Singapore markets closed

Agios Pharmaceuticals, Inc. (AGIO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
29.45+0.47 (+1.62%)
At close: 04:00PM EDT
29.84 +0.39 (+1.32%)
After hours: 05:26PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.55B
Enterprise value 822.11M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)243.14
Price/book (mrq)1.38
Enterprise value/revenue 128.17
Enterprise value/EBITDA -2.13

Trading information

Stock price history

Beta (5Y monthly) 1.18
52-week change 3-32.00%
S&P500 52-week change 3-13.12%
52-week high 350.98
52-week low 316.75
50-day moving average 328.14
200-day moving average 327.06

Share statistics

Avg vol (3-month) 3738.55k
Avg vol (10-day) 3572.19k
Shares outstanding 554.82M
Implied shares outstanding 6N/A
Float 851.09M
% held by insiders 11.34%
% held by institutions 1109.18%
Shares short (14 Sept 2022) 45.68M
Short ratio (14 Sept 2022) 46.64
Short % of float (14 Sept 2022) 411.70%
Short % of shares outstanding (14 Sept 2022) 410.37%
Shares short (prior month 14 Aug 2022) 46.18M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 Jun 2022

Profitability

Profit margin 0.00%
Operating margin (ttm)-6,154.72%

Management effectiveness

Return on assets (ttm)-15.78%
Return on equity (ttm)-25.96%

Income statement

Revenue (ttm)6.41M
Revenue per share (ttm)0.12
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -385.58M
Net income avi to common (ttm)-369.42M
Diluted EPS (ttm)-6.43
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)819.31M
Total cash per share (mrq)14.95
Total debt (mrq)92.22M
Total debt/equity (mrq)8.20
Current ratio (mrq)17.98
Book value per share (mrq)20.51

Cash flow statement

Operating cash flow (ttm)-341.24M
Levered free cash flow (ttm)-232.14M